Society of Cannabis Clinicians

The first and oldest U.S. healthcare organization promoting the use of medical cannabis.

SCC International Chapters

The Society of Cannabis Clinicians has three active chapters in Latin
America, Australia, and the UK with growing communities across the globe.

Black Lives Matter

A statement from the SCC Board of Directors

Who We Are

The SCC is a nonprofit educational and scientific society of healthcare professionals and allies dedicated to advancing research and disseminating knowledge about medical cannabis.

Read On

COURSES

The SCC is a trusted provider of medical cannabis education. In our Clinical Training Curriculum, widely respected experts explain the scientific rationale for cannabis as medicine and the most effective treatment strategies.

Take a look

Research Library

The SCC supports the practice of evidence-based cannabinoid medicine. All articles in the collection have been vetted to ensure only rigorous, unbiased, and non-commercialized studies are included.

Learn more

Certification

The SCC’s Basic Cannabinoid Medicine certification program is specifically designed for health care clinicians who recommend medical cannabis therapy to their patients. All levels of clinicians, from medical students to senior attending physicians and departmental chairs, to advanced practice nurses, to pharmacologists, and to healthcare instructors, will benefit from this five-course curriculum.

View Certification Details

COURSE OFFERINGS

The SCC’s new Clinical Training Curriculum offers education missing from most health professional schools and clinical programs. The curriculum brings hands-on practical guidance on how to develop personalized treatment regimens and more. Continuing education courses enable clinicians to stay up-to-date on emerging topics to ensure patients are receiving the best possible treatment. Scholarships are available, learn more here.

Explore the Courses

Course Packages

All modules also available for individual purchase

5 Course Package: Basics

This 5-course package covers the essential science on the endocannabinoid system, botany, pharmacology, laboratory analysis, and the dosage and delivery of medical cannabis.

Purchase

$229.00

12 Course Package: Basics + Clinical Courses

This 12-course package expands upon the knowledge from the Basic package, giving the user a deeper understanding of medical cannabis education that addresses specific clinical conditions.

Purchase

$499

Comprehensive Clinical Package

The full collection of all 23 modules in the SCC Clinical Training Courses spanning essential science to cannabis therapeutics in clinical practice for specific conditions.

Purchase

$899

Which option best describes you?

I am a student looking to continue my education in medical cannabis

Learn More

I represent a college or university looking to offer cannabis programs or courses

Learn More

Blog

NEWS Apr 28, 2023

Antiviral activities of hemp cannabinoids...

NEWS Mar 11, 2023

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome ...

NEWS Dec 22, 2022

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Trea...

NEWS Aug 11, 2022

Cannabis consumption is associated with lower COVID-19 severity among ho...

View All Posts

Latest News

Covid-19, Herpes, HIV / AIDS, Misc

Antiviral activities of hemp cannabinoids

Hemp is an understudied source of pharmacologically active compounds and many unique plant secondary metabolites including more than 100 cannabinoids. After years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV), and γ-herpes viruses. Mechanisms of action include inhibition of viral cell entry, inhibition of viral proteases, and stimulation of cellular innate immune responses. The anti-inflammatory properties of cannabinoids are also under investigation for mitigating the cytokine storm of COVID-19 and controlling chronic inflammation in people living with HIV. Retrospective clinical studies support antiviral activities of CBD, Δ9-THC, and cannabinoid mixtures as do some prospective clinical trials, but appropriately designed clinical trials of safety and efficacy of antiviral cannabinoids are urgently needed.

Covid-19, Misc

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed “long COVID” or post-acute sequela of COVID-19 (PASC), can implicate persistent neurological complications in up to one third of patients and present as fatigue, “brain fog”, headaches, cognitive impairment, dysautonomia, neuropsychiatric symptoms, anosmia, hypogeusia, and peripheral neuropathy. Pathogenic mechanisms of these symptoms of long COVID remain largely unclear; however, several hypotheses implicate both nervous system and systemic pathogenic mechanisms such as SARS-CoV2 viral persistence and neuroinvasion, abnormal immunological response, autoimmunity, coagulopathies, and endotheliopathy. Outside of the CNS, SARS-CoV-2 can invade the support and stem cells of the olfactory epithelium leading to persistent alterations to olfactory function. SARS-CoV-2 infection may induce abnormalities in innate and adaptive immunity including monocyte expansion, T-cell exhaustion, and prolonged cytokine release, which may cause neuroinflammatory responses and microglia activation, white matter abnormalities, and microvascular changes. Additionally, microvascular clot formation can occlude capillaries and endotheliopathy, due to SARS-CoV-2 protease activity and complement activation, can contribute to hypoxic neuronal injury and blood–brain barrier dysfunction, respectively. Current therapeutics target pathological mechanisms by employing antivirals, decreasing inflammation, and promoting olfactory epithelium regeneration. Thus, from laboratory evidence and clinical trials in the literature, we sought to synthesize the pathophysiological pathways underlying neurological symptoms of long COVID and potential therapeutics.

Covid-19, Misc

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Cannabidiol is showing promising results for the treatment of COVID-19, due to its capa- bility of acting on the unleashed cytokine storm, on the proteins necessary for both virus entry and replication and on the neurological consequences of patients who have been infected by the virus. Here, we summarize the latest knowledge regarding the advantages of using cannabinoids in the treatment of COVID-19.

Covid-19

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users.

Covid-19, Misc

Cannabinoids as Emergent Therapy Against COVID-19

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2(SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massiveimpact. Despite a fast development and implementation of vaccination strategies, and the scouting of severalpharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids repre-sent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. Thismini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far iden-tified for the treatment and prevention of COVID-19, finally considering key aspects related to their technologicaland clinical implementation.

Misc, News

Synergy with Cannabis and Other Herbs: Thinking Beyond Plant Constituents

Explore the different types of plant synergy, herbs that may combine well with cannabis, and the healing properties of botanicals that science will never be able to fully explain.

21 years

As an organization

38 States

Members practice in

24 Countries

Our members represent

711 Articles

in the Research Library

5000

Healthcare Professionals in our Network

Society of Cannabis Clinicians

SCC International Chapters

Black Lives Matter

Who We Are

COURSES

Research Library

Certification

COURSE OFFERINGS

Course Packages

5 Course Package: Basics

12 Course Package: Basics + Clinical Courses

Comprehensive Clinical Package

Which option best describes you?

Blog

Latest News

Antiviral activities of hemp cannabinoids

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

Cannabinoids as Emergent Therapy Against COVID-19

Synergy with Cannabis and Other Herbs: Thinking Beyond Plant Constituents

Global Impact

Affiliates & Allies

BECOME A MEMBER

Get Involved

TAKE OUR COURSES